Robert Dobbins is an experienced clinical development and operations leader currently serving as Head of Clinical Development and Clinical Operations and Clinical Pharmacology Physician at Indivior since July 2017. Previously, Robert held the position of Senior Director of Clinical Research at Cempra Pharmaceuticals, directing Phase 2 clinical trials for infectious and metabolic diseases. Prior experience includes a Senior Director role at GSK, leading external drug development partnerships, and positions as Director and Assistant Professor at UT Southwestern Medical Center, focusing on diabetes and metabolism research. Robert began clinical training as a Resident Physician at Parkland Hospital. Educational qualifications include an M.D. and a Ph.D. in Molecular Physiology and Biophysics from Vanderbilt University, complemented by a Bachelor’s degree in Electrical Engineering and Biomedical Engineering.
This person is not in the org chart
This person is not in any offices